Pasteurellaceae Infections
Pasteurellaceae Infections
Explore linked clinical trials. Standard reference: MESH:M00256745 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Blood-Borne Infections, Clostridium infectious disease, Corynebacterium Infections, DNA Virus Infections, Digestive System Diseases, Hepadnaviridae infectious disease, Infections, Neuroinflammatory Diseases, Pasteurellaceae Infections, Picornaviridae infectious disease, RNA Virus Infections, bacterial infectious disease, bordetellosis, central nervous system disorder, central nervous system infectious disorder, diphtheria, enterovirus infectious disease, gram-negative bacterial infections, gram-positive bacterial infections, haemophilus infectious disease, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, myelitis, nervous system disorder, neuromuscular disease, pertussis, poliomyelitis, respiratory system disorder, respiratory tract infectious disorder, spinal cord disorder, tetanus, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 2 / Phase 3 | 2026-09-03 | NCT06947499 | |
| Study of BK1803 in Healthy Infants | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Blood-Borne Infections, Clostridium infectious disease, Corynebacterium Infections, DNA Virus Infections, Digestive System Diseases, Hepadnaviridae infectious disease, Infections, Neuroinflammatory Diseases, Pasteurellaceae Infections, Picornaviridae infectious disease, RNA Virus Infections, bacterial infectious disease, bordetellosis, central nervous system disorder, central nervous system infectious disorder, diphtheria, enterovirus infectious disease, gram-negative bacterial infections, gram-positive bacterial infections, haemophilus infectious disease, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, myelitis, nervous system disorder, neuromuscular disease, pertussis, poliomyelitis, respiratory system disorder, respiratory tract infectious disorder, spinal cord disorder, tetanus, viral hepatitis, viral infectious disease | Not yet recruiting | Phase 3 | 2026-08-28 | NCT07793513 | |
| Clinical Trial of Lyophilized Haemophilus Influenzae Type b Conjugate Vaccine | Bacterial Infections and Mycoses, Haemophilus influenzae Type b Infection, Infections, Pasteurellaceae Infections, bacterial infectious disease, gram-negative bacterial infections, haemophilus infectious disease | Active, not recruiting | Phase 1 | 2026-08-06 | NCT06621654 | |
| Phase 2 Trial of a Haemophilus Influenzae Serotype a (Hia) Glycoconjugate Vaccine | Bacterial Infections and Mycoses, Infections, Pasteurellaceae Infections, bacterial infectious disease, gram-negative bacterial infections, haemophilus infectious disease | Active, not recruiting | Phase 2 | 2026-08-03 | NCT07743008 | |
| Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Clostridium infectious disease, Corynebacterium Infections, Haemophilus influenzae Type b Infection, Infections, Neisseriaceae Infections, Neuroinflammatory Diseases, Pasteurellaceae Infections, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, diphtheria, gram-negative bacterial infections, gram-positive bacterial infections, haemophilus infectious disease, meningitis, meningococcal infection, meningococcal meningitis, nervous system disorder, tetanus | Recruiting | Phase 1 | 2025-12-31 | NCT07203755 |